Author

Katherine Colvin

Observed institution: Sir Charles Gairdner Hospital

OpenAlex ID: A5064956100

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance

2019 · Joshua W. D. Tobin, Gabrielle Rule, et al. · Blood Advances · 27

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

2020 · Lasse H. Jakobsen, Fredrik Ellin, et al. · British Journal of Haematology · 24

Outcomes of Stage I and II Follicular Lymphoma in the Era of 18F-FDG PET-CT Staging: An International Collaborative Study from the Australian Lymphoma Alliance

2018 · Joshua W.D. Tobin, Gabrielle Rule, et al. · Blood · 3

Immunotherapy in Non-small Cell Lung Cancer: Current and Future Use

2022 · Katherine Colvin · EMJ Oncology

Inferior Outcomes for Older Patients in the Adolescent and Young Adult (AYA) Population with Burkitt Lymphoma Treated with Intensive Immunochemotherapy: An International Study of 108 Patients

2019 · Fredrik Ellin, Knut B. Smeland, et al. · Blood

Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients

2018 · Lasse H. Jakobsen, Fredrik Ellin, et al. · Blood

Works count: 6

Citation count: 54

H-index: 3

I10-index: 2